• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌所致成人尿路感染的流行病学——卡塔尔的一项病例对照研究

Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar.

作者信息

Naushad Vamanjore A, Purayil Nishan K, Wilson Godwin J, Chandra Prem, Joseph Prakash, Khalil Zahida, Zahid Muhammad, Kayakkool Muhammed K, Shaik NoorJahan, Ayari Basma, Chalihadan Sajid, Elmagboul Emad Basheir I, Doiphode Sanjay H

机构信息

General Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

College of Medicine, Qatar University, Doha, Qatar.

出版信息

IJID Reg. 2022 May 4;3:278-286. doi: 10.1016/j.ijregi.2022.05.001. eCollection 2022 Jun.

DOI:10.1016/j.ijregi.2022.05.001
PMID:35755476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9216320/
Abstract

BACKGROUND

Community-acquired urinary tract infection (UTI) is the most common infection caused by extended-spectrum beta-lactamase (ESBL)-producing organisms.

AIM

to estimate the prevalence of ESBL-UTI in adults and to identify potential risk factors that may predispose to ESBL-UTI.

METHODS

A retrospective study involving adult patients with UTI caused by ESBL-producing organisms was undertaken. Patients with UTI caused by non-ESBL-producing organisms represented the control group.

RESULTS

In total, 1100 UTI isolates were included in the study, 277 of which were ESBL positive. The prevalence rate was 25.2%. The mean age of patients was 55.87 years. On univariate analysis, prior history of UTI or ESBL-UTI, invasive urological procedure within preceding 3 months, hospital admission within preceding 3 months, and exposure to antibiotics were found to be significant risk factors for ESBL-UTI. On multi-variate analysis, use of cephalosporins [adjusted odds ratio (OR) 1.61, =0.048], previous ESBL-UTI (adjusted OR 2.67, <0.001), and invasive urological procedure in the preceding year (adjusted OR 1.61, =0.022) were found to be independent risk factors for ESBL-UTI.

CONCLUSIONS

In Qatar, the prevalence of ESBL-UTI in adults is modest. Recent exposure to antibiotics, previous ESBL-UTI and invasive urological procedures were found to be independent risk factors for ESBL-UTI.

摘要

背景

社区获得性尿路感染(UTI)是由产超广谱β-内酰胺酶(ESBL)的微生物引起的最常见感染。

目的

评估成人产ESBL尿路感染(ESBL-UTI)的患病率,并确定可能易患ESBL-UTI的潜在危险因素。

方法

对成年产ESBL微生物所致UTI患者进行一项回顾性研究。非产ESBL微生物所致UTI患者作为对照组。

结果

该研究共纳入1100株UTI分离株,其中277株ESBL阳性。患病率为25.2%。患者的平均年龄为55.87岁。单因素分析发现,UTI或ESBL-UTI既往史、前3个月内的侵入性泌尿外科手术、前3个月内的住院以及抗生素暴露是ESBL-UTI的显著危险因素。多因素分析发现,使用头孢菌素(校正比值比[OR]1.61,=0.048)、既往ESBL-UTI(校正OR 2.67,<0.001)以及前一年的侵入性泌尿外科手术(校正OR 1.61,=0.022)是ESBL-UTI的独立危险因素。

结论

在卡塔尔,成人ESBL-UTI的患病率适中。近期抗生素暴露、既往ESBL-UTI和侵入性泌尿外科手术是ESBL-UTI的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/f18ef75846a9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/0084a1cb0f69/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/12d0025e78a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/99afc00aa7f9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/f18ef75846a9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/0084a1cb0f69/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/12d0025e78a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/99afc00aa7f9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de3f/9216320/f18ef75846a9/gr4.jpg

相似文献

1
Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar.产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌所致成人尿路感染的流行病学——卡塔尔的一项病例对照研究
IJID Reg. 2022 May 4;3:278-286. doi: 10.1016/j.ijregi.2022.05.001. eCollection 2022 Jun.
2
Extended-spectrum beta-lactamase-producing Enterobacteriaceae related urinary tract infection in adult cancer patients: a multicenter retrospective study, 2015-2019.2015-2019 年成人癌症患者中产超广谱β-内酰胺酶肠杆菌科相关尿路感染:一项多中心回顾性研究。
BMC Infect Dis. 2023 Mar 6;23(1):129. doi: 10.1186/s12879-023-08023-3.
3
Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.台湾某医学中心产超广谱β-内酰胺酶肠杆菌科细菌引起的社区获得性尿路感染的流行病学及危险因素:一项前瞻性队列研究
J Microbiol Immunol Infect. 2015 Apr;48(2):168-74. doi: 10.1016/j.jmii.2013.08.006. Epub 2013 Sep 21.
4
Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.儿童中由产超广谱β-内酰胺酶大肠杆菌引起的社区获得性尿路感染的增加。
J Microbiol Immunol Infect. 2014 Oct;47(5):399-405. doi: 10.1016/j.jmii.2013.05.006. Epub 2013 Jul 6.
5
Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.产超广谱β-内酰胺酶肠杆菌科导致的急诊科尿路感染:许多患者无明确的危险因素,且经验性治疗不一致的情况很常见。
Ann Emerg Med. 2018 Oct;72(4):449-456. doi: 10.1016/j.annemergmed.2018.05.006. Epub 2018 Jul 3.
6
Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.产超广谱β-内酰胺酶肠杆菌科细菌所致感染的预测:临床决策列线图的开发
Scand J Urol. 2018 Feb;52(1):70-75. doi: 10.1080/21681805.2017.1373698. Epub 2017 Sep 11.
7
Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.产超广谱β-内酰胺酶细菌引起的尿路感染:危险因素及抗生素耐药性
Pediatr Int. 2019 Nov;61(11):1127-1132. doi: 10.1111/ped.13911. Epub 2019 Nov 13.
8
Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.社区获得性产和不产超广谱β-内酰胺酶的细菌引起的尿路感染:一项比较研究。
J Pediatr. 2013 Nov;163(5):1417-21. doi: 10.1016/j.jpeds.2013.06.078. Epub 2013 Aug 3.
9
Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.肠杆菌科引起小儿下尿路感染的超广谱β-内酰胺酶的分子特征。
Antimicrob Resist Infect Control. 2018 Jul 28;7:90. doi: 10.1186/s13756-018-0381-6. eCollection 2018.
10
Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.产超广谱β-内酰胺酶肺炎克雷伯菌引起的社区获得性尿路感染:病例对照对照研究。
Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.

引用本文的文献

1
Safe and Effective Treatment of Patients with Urinary Tract Infections Caused by Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae via Telemedicine-Controlled Hospital at Home: A Case Series of 11 Patients.通过远程医疗控制的居家医院对产超广谱β-内酰胺酶肠杆菌科细菌引起的尿路感染患者进行安全有效的治疗:11例患者的病例系列
Reports (MDPI). 2024 Apr 26;7(2):31. doi: 10.3390/reports7020031.
2
Fosfomycin resistance in extended-spectrum beta-lactamase producing isolated from urinary tract-infected patients in a tertiary care hospital.在一家三级护理医院中,从尿路感染患者分离出的产超广谱β-内酰胺酶菌株中的磷霉素耐药性。
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002039.
3

本文引用的文献

1
Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.产超广谱β-内酰胺酶大肠埃希菌引起的社区获得性尿路感染的危险因素。
Turk J Med Sci. 2019 Aug 8;49(4):1206-1211. doi: 10.3906/sag-1902-24.
2
National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States.美国住院患者中耐药肠杆菌科和不动杆菌属的全国流行率估计。
Int J Infect Dis. 2019 Aug;85:203-211. doi: 10.1016/j.ijid.2019.06.017. Epub 2019 Jun 20.
3
Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase-Producing Infections-A Retrospective Study of Symptomatic Urinary Tract Infections.
Analysis of phylogroups, biofilm formation, virulence factors, antibiotic resistance and molecular typing of uropathogenic Escherichia coli strains isolated from patients with recurrent and non-recurrent urinary tract infections.
对从复发性和非复发性尿路感染患者中分离出的尿路致病性大肠杆菌菌株的菌系、生物膜形成、毒力因子、抗生素耐药性及分子分型进行分析。
BMC Infect Dis. 2025 Feb 24;25(1):267. doi: 10.1186/s12879-025-10635-w.
4
Prevalence and genetic characterization of clinically relevant extended-spectrum β-lactamase-producing in the Gulf Cooperation Council countries.海湾合作委员会国家中临床相关产超广谱β-内酰胺酶菌株的流行情况及基因特征分析
Front Antibiot. 2023 Jun 26;2:1177954. doi: 10.3389/frabi.2023.1177954. eCollection 2023.
5
Effectiveness of selective antibiotics use in ESBL-related UTIs.ESBL 相关性尿路感染中选择性使用抗生素的效果。
BMC Microbiol. 2024 Sep 21;24(1):360. doi: 10.1186/s12866-024-03495-y.
6
Prevalence and risk factors of extended-spectrum beta-lactamase producing E. coli causing urinary tract infections in Iceland during 2012-2021.2012-2021 年冰岛产超广谱β-内酰胺酶大肠埃希菌引起尿路感染的流行状况及危险因素分析。
Eur J Clin Microbiol Infect Dis. 2024 Sep;43(9):1689-1697. doi: 10.1007/s10096-024-04882-z. Epub 2024 Jun 27.
7
Diversity of uropathogens and their antibiotic resistance among diabetic patients presented to MTI-Lady Reading Hospital, Peshawar.白沙瓦市女读医院MTI就诊的糖尿病患者中尿路病原体的多样性及其抗生素耐药性
Pak J Med Sci. 2024 May-Jun;40(5):985-988. doi: 10.12669/pjms.40.5.8275.
8
Association Between Proton Pump Inhibitor Use and Extended-Spectrum Beta-Lactamase Urinary Tract Infection in Adults: A Retrospective Study.成人使用质子泵抑制剂与产超广谱β-内酰胺酶尿路感染之间的关联:一项回顾性研究
Infect Drug Resist. 2023 Jun 29;16:4251-4258. doi: 10.2147/IDR.S415096. eCollection 2023.
9
Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India.印度北部东部地区引起尿路感染的尿路病原体的细菌谱及抗生素敏感性模式
Front Microbiol. 2022 Aug 9;13:965053. doi: 10.3389/fmicb.2022.965053. eCollection 2022.
社区获得性产超广谱β-内酰胺酶感染的危险因素——有症状尿路感染的回顾性研究
Open Forum Infect Dis. 2019 Jan 3;6(2):ofy357. doi: 10.1093/ofid/ofy357. eCollection 2019 Feb.
4
Extended-spectrum β-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan.产超广谱β-内酰胺酶大肠埃希菌引起的尿路感染:在约旦安曼进行的一项关于患病率、基因型和危险因素的两中心、横断面研究。
J Infect Public Health. 2019 Jan-Feb;12(1):21-25. doi: 10.1016/j.jiph.2018.07.011. Epub 2018 Aug 23.
5
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.丹麦社区中产超广谱β-内酰胺酶大肠埃希菌尿路感染的危险因素:一项病例对照研究。
Clin Microbiol Infect. 2017 Dec;23(12):952-960. doi: 10.1016/j.cmi.2017.03.026. Epub 2017 Apr 1.
6
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.2011 - 2012年土耳其SMART研究中病原体的流行病学及易感性:医院获得性与社区获得性尿路感染以及重症监护病房相关与非重症监护病房相关腹腔内感染的评估
J Antimicrob Chemother. 2017 May 1;72(5):1364-1372. doi: 10.1093/jac/dkw574.
7
Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.产超广谱β-内酰胺酶(ESBLs)在复发性尿路感染门诊患者大肠埃希菌分离株中的分布及其耐药性。
J Infect Dev Ctries. 2016 Jun 30;10(6):575-83. doi: 10.3855/jidc.6661.
8
Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014.2010 - 2014年加拿大和美国泌尿系统感染大肠埃希菌的药敏模式及超广谱β-内酰胺酶率
Diagn Microbiol Infect Dis. 2016 Aug;85(4):459-65. doi: 10.1016/j.diagmicrobio.2016.04.022. Epub 2016 May 6.
9
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013.2013 年法国社区获得性尿路感染中产超广谱β-内酰胺酶大肠埃希菌的流行情况。
J Infect. 2016 Feb;72(2):201-6. doi: 10.1016/j.jinf.2015.11.009. Epub 2015 Dec 15.
10
Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.2013 年德国莱茵-美因地区长期护理机构中多重耐药菌的现患率。
Euro Surveill. 2015 Jul 2;20(26):21171. doi: 10.2807/1560-7917.es2015.20.26.21171.